These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6165129)

  • 81. Combination of vinblastine and bleomycin in metastatic renal cell carcinoma.
    Knost JA; Oldham RK; Hande KR; Rhamy RK; Greco FA
    Cancer Treat Rep; 1981; 65(3-4):349-50. PubMed ID: 6165469
    [No Abstract]   [Full Text] [Related]  

  • 82. [A case of advanced prostatic cancer in a 44-year-old treated effectively with combination chemo-endocrine therapy].
    Araki S; Kusuyama H; Kato M; Okada K
    Hinyokika Kiyo; 1990 Apr; 36(4):465-9. PubMed ID: 1696064
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
    Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
    Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Chemotherapy of Hodgkin's disease].
    Amiel JL; Mathé G
    Rev Prat; 1974 Oct; 24(45):3957-60, 3963-4, 3967-8. PubMed ID: 4141118
    [No Abstract]   [Full Text] [Related]  

  • 85. Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphoma.
    Goldhirsch A; Pirovino M; Sonntag RW; Tschopp L; Ryssel HJ; Brunner KW
    Cancer Treat Rep; 1980; 64(2-3):335-7. PubMed ID: 6157468
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
    Smalley RV; Bartolucci AA; Hemstreet G; Hester M
    J Urol; 1981 Feb; 125(2):191-5. PubMed ID: 7206052
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.
    Schein PS; DeVita VT; Hubbard S; Chabner BA; Canellos GP; Berard C; Young RC
    Ann Intern Med; 1976 Oct; 85(4):417-22. PubMed ID: 61732
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Acute bleomycin and methotrexate toxicity: report of two cases.
    Porcile G; Brema F; Stefani G; Campora E; Rosso R; Santi L
    Tumori; 1982 Aug; 68(4):355-8. PubMed ID: 6183807
    [No Abstract]   [Full Text] [Related]  

  • 89. Overview of chemotherapy programs of the NPCP.
    Slack NH; Murphy GP
    Prostate; 1980; 1(3):367-73. PubMed ID: 7279806
    [No Abstract]   [Full Text] [Related]  

  • 90. Vincristine and bleomycin do not interfere with infusional plasma levels of methotrexate.
    Ottolenghi I; Piazza E; Marsoni S; Trabattoni A; Natale N; Recchia M; Morasca L
    Eur J Cancer (1965); 1981 Mar; 17(3):365-6. PubMed ID: 6167447
    [No Abstract]   [Full Text] [Related]  

  • 91. Vincristine, bleomycin, methotrexate, 5-fluorouracil, and prednisone in metastatic, hormonally unresponsive prostatic adenocarcinoma.
    Paulson DF; Walker RA; Berry WR; Cox EB; Hinshaw W
    Urology; 1981 May; 17(5):443-5. PubMed ID: 6165129
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report.
    Kane RD; Stocks LH; Paulson DF
    J Urol; 1977 Apr; 117(4):467-71. PubMed ID: 850320
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.
    Graham SD; Walker A; Cox EB; Laszlo J; Berry WR; Paulson DF
    Urology; 1986 Nov; 28(5):404-8. PubMed ID: 3538611
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Chemotherapy of hormone-unresponsive prostatic cancer and its metastatic foci].
    Kotake T
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):387-96. PubMed ID: 6764105
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Chemotherapy trial with comp-F regimen in advanced adenocarcinoma of prostate.
    Buell GV; Saiers JH; Saiki JH; Bergreen PW
    Urology; 1978 Mar; 11(3):247-50. PubMed ID: 636128
    [TBL] [Abstract][Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.